DaVita (DVA) Competitors $133.08 -0.16 (-0.12%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$134.28 +1.19 (+0.90%) As of 09/12/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DVA vs. ALGN, DXCM, HQY, MMSI, CAH, COR, EHC, HAE, ITGR, and MCKShould you be buying DaVita stock or one of its competitors? The main competitors of DaVita include Align Technology (ALGN), DexCom (DXCM), HealthEquity (HQY), Merit Medical Systems (MMSI), Cardinal Health (CAH), Cencora (COR), Encompass Health (EHC), Haemonetics (HAE), Integer (ITGR), and McKesson (MCK). These companies are all part of the "medical" sector. DaVita vs. Its Competitors Align Technology DexCom HealthEquity Merit Medical Systems Cardinal Health Cencora Encompass Health Haemonetics Integer McKesson Align Technology (NASDAQ:ALGN) and DaVita (NYSE:DVA) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends and profitability. Do analysts prefer ALGN or DVA? Align Technology presently has a consensus target price of $215.00, suggesting a potential upside of 63.42%. DaVita has a consensus target price of $158.00, suggesting a potential upside of 18.73%. Given Align Technology's stronger consensus rating and higher probable upside, research analysts plainly believe Align Technology is more favorable than DaVita.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Align Technology 2 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.50DaVita 1 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.75 Which has stronger earnings and valuation, ALGN or DVA? DaVita has higher revenue and earnings than Align Technology. DaVita is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlign Technology$3.96B2.41$421.36M$5.9322.19DaVita$13.16B0.72$936.34M$10.1713.09 Which has more risk and volatility, ALGN or DVA? Align Technology has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500. Comparatively, DaVita has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Is ALGN or DVA more profitable? Align Technology has a net margin of 11.04% compared to DaVita's net margin of 6.35%. DaVita's return on equity of 369.39% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Align Technology11.04% 13.36% 8.32% DaVita 6.35%369.39%4.62% Do insiders and institutionals hold more shares of ALGN or DVA? 88.4% of Align Technology shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 0.7% of Align Technology shares are held by insiders. Comparatively, 1.5% of DaVita shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media favor ALGN or DVA? In the previous week, Align Technology had 10 more articles in the media than DaVita. MarketBeat recorded 27 mentions for Align Technology and 17 mentions for DaVita. Align Technology's average media sentiment score of 1.24 beat DaVita's score of 0.93 indicating that Align Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 16 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 10 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAlign Technology beats DaVita on 11 of the 17 factors compared between the two stocks. Get DaVita News Delivered to You Automatically Sign up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DVA vs. The Competition Export to ExcelMetricDaVitaMED IndustryMedical SectorNYSE ExchangeMarket Cap$9.53B$5.45B$5.85B$21.59BDividend YieldN/A1.28%5.68%3.48%P/E Ratio13.0929.0175.3429.75Price / Sales0.72162.30514.9786.29Price / Cash6.9627.2237.5625.00Price / Book27.554.5212.154.58Net Income$936.34M$189.47M$3.29B$999.94M7 Day Performance-3.37%-0.48%0.75%0.68%1 Month Performance-1.13%2.03%4.82%3.10%1 Year Performance-18.64%14.37%60.59%14.39% DaVita Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DVADaVita4.6648 of 5 stars$133.08-0.1%$158.00+18.7%-15.6%$9.53B$13.16B13.0976,000Analyst ForecastALGNAlign Technology4.9561 of 5 stars$136.86-1.6%$215.00+57.1%-42.5%$9.92B$4.00B23.0820,945Positive NewsDXCMDexCom4.9686 of 5 stars$78.00-3.1%$99.89+28.1%+10.8%$30.59B$4.03B54.1710,300Positive NewsHQYHealthEquity4.4631 of 5 stars$93.06+1.7%$119.77+28.7%+20.8%$8.02B$1.20B56.403,120News CoverageMMSIMerit Medical Systems4.7807 of 5 stars$92.33-0.7%$107.00+15.9%-10.9%$5.47B$1.36B46.877,400News CoveragePositive NewsCAHCardinal Health4.9519 of 5 stars$150.29+0.5%$165.93+10.4%+35.6%$35.89B$222.58B23.3057,700Positive NewsCORCencora4.8036 of 5 stars$297.64+1.8%$311.25+4.6%+27.4%$57.71B$638.56M30.6246,000News CoveragePositive NewsEHCEncompass Health4.7243 of 5 stars$125.93+0.3%$134.00+6.4%+36.1%$12.68B$5.37B24.6440,000Analyst ForecastShort Interest ↑HAEHaemonetics4.8955 of 5 stars$54.02-0.7%$85.18+57.7%-28.7%$2.60B$1.36B16.523,023News CoverageAnalyst RevisionITGRInteger3.9873 of 5 stars$106.01-0.9%$140.25+32.3%-19.6%$3.71B$1.72B46.7011,000Positive NewsMCKMcKesson4.5508 of 5 stars$696.53+1.3%$725.10+4.1%+39.2%$86.63B$359.05B27.7745,000News CoveragePositive News Related Companies and Tools Related Companies ALGN Competitors DXCM Competitors HQY Competitors MMSI Competitors CAH Competitors COR Competitors EHC Competitors HAE Competitors ITGR Competitors MCK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DVA) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DaVita Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DaVita With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
